. Author manuscript; available in PMC: 2020 Apr 18.

Published before final editing as: J Psychopharmacol. 2018 Oct 18:269881118805488. doi: 10.1177/0269881118805488

Table 1.

Experimental groups.

Group	Drug	n	Age	Time	Procedure	Data
1	CON	10	PD35–49	24 h	Tail suspension test (PD50)	Figure 2(b) and (c)
1	FLX	10	PD35–49	24 h	Tail suspension test (PD50)	Figure 2(b) and (c)
2	CON	41	PD35–49	21 d	Cocaine place preference (PD70–75)	Figure 3(a)
2	FLX	40	PD35–49	21 d	Cocaine place preference (PD70–75)	Figure 3(a)
3	CON	12	PD35–49	21 d	Sucrose preference (PD70–75) PD35–49	Figure 3(b) and (c)
3	FLX	12	PD35–49	21 d	Sucrose preference (PD70–75) PD35–49	Figure 3(b) and (c)
4	CON	10	PD70–84	24 h	Tail suspension test (PD85)	Figure 4(b) and (c)
4	FLX	10	PD70–84	24 h	Tail suspension test (PD85)	Figure 4(b) and (c)
5	CON	40	PD70–84	21 d	Cocaine place preference (PD105–110)	Figure 5(a)
5	FLX	40	PD70–84	21 d	Cocaine place preference (PD105–110)	Figure 5(a)
6	CON	12	PD70–84	21 d	Sucrose preference (PD105–110)	Figure 5(b) and (c)
6	FLX	12	PD70–84	21 d	Sucrose preference (PD105–110)	Figure 5(b) and (c)

CON: control; d, day; FLX: fluoxetine; h, hour; PD: postnatal day.